Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men-Reference-Cited by-同舟云学术

Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men

Published:2012-09-12 Issue:151 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Anderson Peter L.¹,Glidden David V.²,Liu Albert³,Buchbinder Susan²³,Lama Javier R.⁴⁵,Guanira Juan Vicente⁵,McMahan Vanessa⁶,Bushman Lane R.¹,Casapía Martín⁷,Montoya-Herrera Orlando⁸,Veloso Valdilea G.⁹,Mayer Kenneth H.¹⁰¹¹,Chariyalertsak Suwat¹²,Schechter Mauro¹³,Bekker Linda-Gail¹⁴,Kallás Esper Georges¹⁵¹⁶,Grant Robert M.²⁶,

Affiliation:

1. University of Colorado Denver, Aurora, CO 80045, USA.

2. University of California, San Francisco, San Francisco, CA 94143, USA.

3. HIV Research Section, San Francisco Department of Public Health, San Francisco, CA 94102, USA.

4. Investigaciones Medicas en Salud, Lima 14, Peru.

5. Asociación Civil Impacta Salud y Educación, Lima, Peru.

6. Gladstone Institute of Virology and Immunology, San Francisco, CA 94158, USA.

7. Asociación Civil Selva Amazónica, Iquitos, Maynas, Peru.

8. Fundación Ecuatoriana Equidad, Guayaquil-Guayas, Ecuador.

9. Instituto de Pesquisa Clinica Evandro Chagas, Fundação Oswaldo Cruz, Manguinhos, Rio de Janeiro CEP 21040-900, Brazil.

10. Brown University, Providence, RI 02912, USA.

11. Fenway Institute, Fenway Health, Boston, MA 02215, USA.

12. Research Institute for Health Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

13. Projeto Praça Onze, Hospital Escola São Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro CEP 20.210-030, Brazil.

14. Desmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town 7925, South Africa.

15. Division of Clinical Immunology and Allergy, School of Medicine, University of São Paulo, São Paulo, SP 05403-000, Brazil.

16. Instituto de Investigação em Imunologia, Cerqueira Cesar, São Paulo, SP CEP 05403-900, Brazil.

Abstract

PrEP drug concentrations associated with ≥90% reduction in HIV acquisition in men who have sex with men are achieved with daily dosing.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference27 articles.

1. Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

2. UNAIDS 2010.

3. Elevated Risk for HIV Infection among Men Who Have Sex with Men in Low- and Middle-Income Countries 2000–2006: A Systematic Review

4. D. Donnell et al. paper presented at the 19th Conference on Retroviruses and Opportunistic Infections Seattle WA 5 to 8 March 2012.

5. Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women

Cited by 828 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations Between PrEP Stigma, PrEP Confidence, and PrEP Adherence: Conditional Indirect Effects of Anticipated HIV Stigma;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-10-01

2. Transgender-Specific Differentiated HIV Service Delivery Models in the South African Public Primary Health Care System (Jabula Uzibone): Protocol for an Implementation Study;JMIR Research Protocols;2024-09-13

3. Pharmacogenetic determinants of tenofovir diphosphate and lamivudine triphosphate concentrations in people with HIV/HBV coinfection;Antimicrobial Agents and Chemotherapy;2024-09-04

4. Weighing the Options: Which PrEP (Pre-exposure Prophylaxis) Modality Attributes Influence Choice for Young Gay and Bisexual Men in the United States?;AIDS and Behavior;2024-08-10

5. Adherence and HIV Protection Thresholds for Emtricitabine and Tenofovir Disoproxil Fumarate Preexposure Prophylaxis among Cisgender Women: A Systematic Review;Current HIV/AIDS Reports;2024-08-09